...
机译:建立艾滋病毒耐药性评估的能力:药事非洲研究的经验评价阻力网络
PharmAccess Foundation and Department of Global Health Academic Medical Center of the University;
PharmAccess Foundation and Department of Global Health Academic Medical Center of the University;
Joint Clinical Research Centre Kampala Uganda;
Department of Molecular Medicine and Haematology University of the Witwatersrand Johannesburg;
Department of Molecular Medicine and Haematology University of the Witwatersrand Johannesburg;
PharmAccess Foundation and Department of Global Health Academic Medical Center of the University;
Lusaka Trust Hospital Zambia;
Clinical HIV Research Unit University of the Witwatersrand Johannesburg South Africa;
Muelmed Hospital Pretoria South Africa;
Coast Province General Hospital International Centre for Reproductive Health Mombasa Kenya;
Newlands Clinic Harare Zimbabwe;
Lagos University Teaching Hospital Nigeria;
PharmAccess Foundation and Department of Global Health Academic Medical Center of the University;
PharmAccess Foundation and Department of Global Health Academic Medical Center of the University;
机译:评估艾滋病毒耐药性的能力建设:通过非洲药物研究评估耐药性网络的经验
机译:建立艾滋病毒耐药性评估的能力:药事非洲研究的经验评价阻力网络
机译:评估艾滋病毒抗药性的能力建设:从PharmAccess非洲研究到评估抗药性网络的经验
机译:肠球菌临床分离株的耐药性研究,特别是高水平氨基糖苷抵抗,β内酰胺酶生产和耐药性横向转移
机译:阿根廷布宜诺斯艾利斯的一家艾滋病诊所Helios Salud影响患者对HIV耐药的因素
机译:队列简介:非洲PharmAccess(PASER-M)和TREAT Asia(TASER-M)监测研究以评估耐药性-撒哈拉以南非洲和亚太地区的HIV耐药性
机译:建设艾滋病毒耐药性评估的能力:药物成交非洲研究的经验评价阻力网络